Nilo Therapeutics
Boston, United States· Est.
Nilo Therapeutics develops targeted protein degradation therapies, focusing on molecular glues to treat cancer and other diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $101M
About
Nilo Therapeutics develops targeted protein degradation therapies, focusing on molecular glues to treat cancer and other diseases.
OncologySmall Molecules
Funding History
1Total raised:$101M
Venture$101M